SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease)
- PMID: 32405072
- PMCID: PMC7217792
- DOI: 10.1016/j.amjmed.2020.03.057
SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease)
Comment in
-
A new diagnosis of systemic capillary leak syndrome in a patient with COVID-19.Rheumatology (Oxford). 2021 Jan 5;60(1):e19-e20. doi: 10.1093/rheumatology/keaa606. Rheumatology (Oxford). 2021. PMID: 32940700 Free PMC article. No abstract available.
References
-
- Clarkson B, Thompson D, Horwith M, Luckey EH. Cyclical edema and shock due to increased capillary permeability. Am J Med. 1960;29(2):193–216. - PubMed
-
- Pineton de Chambrun M, Gousseff M, Mauhin W. Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome. Am J Med. 2017;130(10) 1219.e19–1219.e27. - PubMed
-
- Gousseff M, Arnaud L, Lambert M. The systemic capillary leak syndrome: a case series of 28 patients from a European registry. Ann Intern Med. 2011;154(7):464–471. - PubMed
-
- Pineton de Chambrun M, Luyt C-E, Beloncle F. The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission. Crit Care Med. 2017;45(7):1216–1223. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous